In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Lifestyle changes could prevent 400 cardiac events and 200 deaths in Swedish PCI patients

Life after PCI and TAVI

Munich, Germany – August 27 2012: Up to 400 cardiac events and 200 deaths in Swedish PCI patients could be avoided by following a heart healthy lifestyle, according to research from the SPICI study presented at ESC Congress 2012. The results were presented at ESC press conference by Professor Joep Perk from Linnaeus University and at the scientific session by Dr Roland CARLSSON.


The benefits of adherence to a heart healthy lifestyle in combination with drug treatment after an acute myocardial infarction treated with coronary artery balloon intervention (PCI) have recently been examined. The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS-5) trial showed an up to four-fold reduction of new cardiac events within six months after PCI among patients who followed lifestyle recommendations as compared to those who failed to do so.

The Study of Patient Information after Coronary Intervention (SPICI) investigated the possible gains of a heart healthy lifestyle in a large sample of Swedish patients after PCI (n=1073, 26% females, 74% males, average age 66 years). Within the first two months after PCI patients were asked to report on their current use of tobacco, physical activity and food habits.

The researchers found that although half of the previous smokers had quit, 16% still continued to use tobacco. Following nutritional guidance was reported by 55% but only 40% had changed their dietary habits. Approximately 50% were engaged in regular physical activity, mainly through training sessions in patient groups, but only 31% had actually increased their activity after PCI.

“A possible explanation may be the finding that many patients rated heredity and age as a more plausible cause of their disease than smoking, a lack of physical activity or poor food habits,” said Professor Perk. “Furthermore, a majority reported that as a result of PCI they were cured from the underlying coronary heart disease, thus adding to a lack of interest in changing lifestyle.”

“Each year 18,000 patients undergo PCI in Sweden,” he added. “Using the data from the OASIS-5 study we estimate the expected event rate in the Swedish population during the first half year after PCI to be more than 1,000 new cardiac events (myocardial infarction, stroke and cardiovascular death).”

He continued: “If a 100% compliance to lifestyle recommendations could be reached among our patients instead of the less than satisfactory outcome in the present study there may be major health benefits: one third of the events in Sweden might be prevented annually. That equates to preventing 300 to 400 cardiac events, of which 150 to 200 would have resulted in death.”

Professor Perk concluded: “Current practice after PCI in Sweden needs an in-depth revision. Greater emphasis on lifestyle factors and on methods to support a long-term commitment to behavioural change, are urgently needed.”

ENDS

References

This press release accompanies both a presentation and an ESC press conference at the ESC Congress 2012. The press release has been written by the investigator and edited by the ESC and does not necessarily reflect the opinion of the European Society of Cardiology.

Refers to session:  Poster session 4: Percutaneous coronary interventions. Miscellaneous

Refers to press conference:  Life after PCI and TAVI

Notes to editor

About the European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 75,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

About ESC Congress 2012
ESC Congress 2012 will take place from 25 to 29 August at the Messe München centre in Munich, Germany. Information on the scientific programme is available here. More information on ESC Congress 2012 is available from the ESC Press Office or contact us at press@escardio.org